文献速递类风湿关节炎

类风湿关节炎患者的经济困扰及其决定因素

Financial Distress and Its Determinants in Rheumatoid Arthritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2025-12-15

本研究基于FORWARD数据库的横断面分析,纳入2277例类风湿关节炎(RA)和1340例非炎性肌肉骨骼疾病(NIMSKD)成人患者,采用FACIT-COST问卷评估经济困扰。RA患者FACIT-COST评分更低(30.2±9.4 vs 34.0±8.4,未校正P<0.001),经济困扰更常见(29% vs 15%,未校正P<0.001),多变量校正后差异持续存在。RA患者中抑郁与疾病严重程度为经济困扰的决定因素,而昂贵的生物或靶向合成改善病情抗风湿药与FACIT-COST评分无关。

要点

  • RA患者经济困扰较NIMSKD更常见(29% vs 15%,未校正P<0.001)。
  • RA患者FACIT-COST评分更低(30.2±9.4 vs 34.0±8.4,未校正P<0.001),提示经济困扰更重。
  • RA患者中抑郁与疾病严重程度为经济困扰的决定因素。

核心结论

  • 经济困扰在RA成人中普遍存在,且在合并症(特别是抑郁)患者中似乎最严重,提示潜在干预领域。
  • 昂贵的生物或靶向合成改善病情抗风湿药与FACIT-COST评分无关。

研究设计与样本

  • 横断面研究,纳入FORWARD数据库中完成FACIT-COST问卷的RA或NIMSKD成人患者。
  • RA患者n=2277,NIMSKD患者n=1340。
  • FACIT-COST作为连续变量(评分越高表示经济困扰越轻)和二分类变量(经济困扰阈值<26)分析。
  • 采用LASSO应用于线性与逻辑回归以选择协变量纳入多变量模型。

主要发现

  • RA患者FACIT-COST评分低于NIMSKD患者(均值30.2±SD 9.4 vs 均值34.0±SD 8.4;未校正P<0.001),提示经济困扰更重。
  • 以二分类结局评估,RA患者经济困扰较NIMSKD患者更常见(29% vs 15%;未校正P<0.001)。
  • 按诊断分类的经济困扰差异在多变量校正后持续存在。
  • RA患者中多变量模型识别的决定因素包括抑郁(校正比值比1.12;95%置信区间1.09-1.16)和疾病严重程度。
  • 昂贵的生物或靶向合成改善病情抗风湿药与FACIT-COST评分无关。

关键数值与推荐

  • FACIT-COST评分越高表示经济困扰越轻;经济困扰定义为评分<26。
  • RA患者FACIT-COST均值30.2±SD 9.4 vs NIMSKD患者均值34.0±SD 8.4(未校正P<0.001)。
  • RA患者经济困扰29% vs NIMSKD患者15%(未校正P<0.001)。
  • RA患者中抑郁的校正比值比1.12(95%置信区间1.09-1.16)。

临床怎么用

  • 原文结论指出经济困扰在RA成人中普遍存在,在合并症(特别是抑郁)患者中似乎最严重,识别出潜在干预领域。
  • 原文报告昂贵的生物或靶向合成改善病情抗风湿药与FACIT-COST评分无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To quantify the degree of financial distress and identify its determinants in adults with rheumatoid arthritis (RA) given the frequent prolonged use of expensive disease-modifying therapies. METHODS: We identified adults enrolled in the FORWARD databank with either RA or noninflammatory musculoskeletal disease (NIMSKD) completing the Functional Assessment of Chronic Illness Therapy-Comprehensive Score for Financial Toxicity (FACIT-COST) questionnaire. In this cross-sectional study, FACIT-COST was analyzed as a continuous (higher score indicates less financial distress) and binary variable (presence of financial distress with threshold <26). Least Absolute Shrinkage and Selection Operator (LASSO) was applied to linear and logistic regression to select covariates for inclusion in multivariable models. RESULTS: Participants with RA (n = 2,277) had lower FACIT-COST scores, indicating greater financial distress, than those with NIMSKD (n = 1,340) (mean of 30.2 ± SD 9.4 vs mean of 34.0 ± SD 8.4; unadjusted P < 0.001). Assessed as a binary outcome, financial distress was more frequent in participants with RA than participants with NIMSKD (29% vs 15%; unadjusted P < 0.001). Differences in financial distress by diagnosis persisted following multivariable adjustment. Among those with RA, determinants identified in multivariable models included depression (adjusted odds ratio 1.12; 95% confidence interval 1.09-1.16) and disease severity. CONCLUSION: Financial distress is prevalent in adults with RA and appears to be greatest in those with comorbidities, specifically depression, identifying a potential area for intervention. Notably, expensive biologic or targeted synthetic disease-modifying antirheumatic drugs were not associated with FACIT-COST scores.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Keebler AB, Im Y, Pedro S, et al. Financial Distress and Its Determinants in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2025. PMID: 41098026. doi:10.1002/acr.25670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。